BLT 2- lidocaine hcl ointment 
CENTURA PHARMACEUTICALS INC

----------

ACTIVE INGREDIENT

Lidocaine HCL 4%

PURPOSE

Topical Anesthetic

USES

For the temporary relief of pain and itching.

WARNINGS

• For external use only.
• Avoid contact with eyes or mucus membranes.
• Do not apply to open or damaged skin.
• If condition worsens or symptoms persist for
more than seven days, discontinue use and
consult physician.
• If pregnant or breast feeding,contact physician
prior to use.
• Keep out of reach of children. If swallowed,
contact Poison Control Center.
• Do not use if allergic to any ingredient in ointment.
• Do not use in large quantities, particularly over
raw surfaces or blistered areas.

DIRECTIONS

Adults and children two-years of age or
older: Apply to affected area not more than three to
four times daily. Children under two-years of age:
consult a physician.

OTHER INFORMATION

Store below 77° F (25° C). Avoid
direct sunlight.

INACTIVE INGREDIENTS

Acrylates, C10-30 Alkyl Acrylate Crosspolymer, Aqua (Deionized Water), Beeswax, Benzyl Alcohol, Cetyl Alcohol, Dehydroacetic Acid, Glycerin, Helianthus Anuus (Sunflower) Oil, Polysorbate 20, Sodium Hydroxide, Stearic Acid.

KEEP OUT OF REACH OF CHILDREN

PACKAGE LABELING

BLT 2

BLT 2 
lidocaine hcl ointment
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:70372-728
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LIDOCAINE HYDROCHLORIDE (UNII: V13007Z41A) (LIDOCAINE - UNII:98PI200987) LIDOCAINE HYDROCHLORIDE ANHYDROUS4 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
GLYCERIN (UNII: PDC6A3C0OX)  
SUNFLOWER OIL (UNII: 3W1JG795YI)  
CARBOMER INTERPOLYMER TYPE A (ALLYL SUCROSE CROSSLINKED) (UNII: 59TL3WG5CO)  
BENZYL ALCOHOL (UNII: LKG8494WBH)  
POLYSORBATE 20 (UNII: 7T1F30V5YH)  
CETYL ALCOHOL (UNII: 936JST6JCN)  
YELLOW WAX (UNII: 2ZA36H0S2V)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
DEHYDROACETIC ACID (UNII: 2KAG279R6R)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
WATER (UNII: 059QF0KO0R)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:70372-728-015 g in 1 POUCH; Type 0: Not a Combination Product11/21/2016
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01711/21/2016
Labeler - CENTURA PHARMACEUTICALS INC (084921637)
Registrant - CENTURA PHARMACEUTICALS INC (084921637)

Revised: 2/2024
Document Id: 10942f9a-c8f5-6629-e063-6394a90a83e3
Set id: 41dc85ec-d79b-0a32-e054-00144ff8d46c
Version: 6
Effective Time: 20240204
 
CENTURA PHARMACEUTICALS INC